PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10

Reported: April 3, 2024 Initiated: December 26, 2023 #D-0426-2024

Product Description

Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10

Reason for Recall

Failed dissolution specifications

Details

Units Affected
21,452/100 count bottles
Distribution
Product was distributed nationwide.
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10. Recalled by Amneal Pharmaceuticals of New York, LLC. Units affected: 21,452/100 count bottles.
Why was this product recalled?
Failed dissolution specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on April 3, 2024. Severity: Moderate. Recall number: D-0426-2024.